SAN DIEGO, Calif. (GenomeWeb News) – Industry experts at the Discovery 2 Diagnostics Conference held here this week urged microarray firms developing molecular diagnostic products to take a more global view and focus on reimbursement to increase the likelihood of their products succeeding in the marketplace.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.